COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens (RZD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01502085
Recruitment Status : Unknown
Verified August 2015 by Hackensack Meridian Health.
Recruitment status was:  Active, not recruiting
First Posted : December 30, 2011
Last Update Posted : August 24, 2015
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Hackensack Meridian Health

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : May 2016